These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29500901)

  • 1. Reply.
    Verma N; Singh A; Singh V
    Hepatology; 2018 Jul; 68(1):388. PubMed ID: 29500901
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis'.
    Petta S; Marra F
    J Hepatol; 2016 Apr; 64(4):984-5. PubMed ID: 26812076
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver fibrosis and cirrhosis--selected cytokines, growth factors and proteins. Part II].
    Wirkowska A; Paczek L
    Przegl Lek; 2011; 68(4):228-30. PubMed ID: 21853679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis.
    Marí M; Tutusaus A; García de Frutos P; Morales A
    J Hepatol; 2016 Apr; 64(4):983-4. PubMed ID: 26820628
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth factor therapy for decompensated cirrhosis: Much ado about nothing?
    Philips CA; Augustine P; Mathew S; Valiathan GC; John SK
    Hepatology; 2018 Jul; 68(1):387-388. PubMed ID: 29500913
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.
    Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
    Liver Int; 2005 Feb; 25(1):28-32. PubMed ID: 15698395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatic apelin system: a new therapeutic target for liver disease.
    Principe A; Melgar-Lesmes P; Fernández-Varo G; del Arbol LR; Ros J; Morales-Ruiz M; Bernardi M; Arroyo V; Jiménez W
    Hepatology; 2008 Oct; 48(4):1193-201. PubMed ID: 18816630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia in chronic liver disease: lessons from transplanted patients.
    Laffi G; Tarquini R; Marra F
    J Hepatol; 2007 Nov; 47(5):625-9. PubMed ID: 17869369
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular targets in the design of antifibrotic therapy in chronic liver disease.
    Solís Herruzo JA; Solís-Muñoz P; Muñoz Yagüe T; García-Ruiz I
    Rev Esp Enferm Dig; 2011 Jun; 103(6):310-23. PubMed ID: 21736398
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
    Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
    J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
    J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adipocentric view of liver fibrosis and cirrhosis.
    Chuang JH; Wang PW; Tai MH
    Chang Gung Med J; 2004 Dec; 27(12):855-68. PubMed ID: 15754775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas6 as a putative noninvasive biomarker of hepatic fibrosis.
    Bellan M; Pogliani G; Marconi C; Minisini R; Franzosi L; Alciato F; Magri A; Avanzi GC; Pirisi M; Sainaghi PP
    Biomark Med; 2016 Dec; 10(12):1241-1249. PubMed ID: 27924629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling enhances the activation and survival of human hepatic stellate cells.
    Myung SJ; Yoon JH; Gwak GY; Kim W; Lee JH; Kim KM; Shin CS; Jang JJ; Lee SH; Lee SM; Lee HS
    FEBS Lett; 2007 Jun; 581(16):2954-8. PubMed ID: 17544413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis.
    Zhang F; Lu Y; Zheng S
    Cell Signal; 2012 Mar; 24(3):596-605. PubMed ID: 22108088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis.
    Lim YL; Choi E; Jang YO; Cho YZ; Kang YS; Baik SK; Kwon SO; Kim MY
    Gut Liver; 2016 Jan; 10(1):109-16. PubMed ID: 25963087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells.
    Zeng Z; Wu Y; Cao Y; Yuan Z; Zhang Y; Zhang DY; Hasegawa D; Friedman SL; Guo J
    Life Sci; 2018 Jun; 203():39-47. PubMed ID: 29660433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral solution of nutritional hepatotrophic factors improves regeneration in thioacetamide-induced cirrhotic livers after partial hepatectomy.
    Trotta Mde R; Cajaiba DM; Parra OM; Dagli ML; Hernandez-Blazquez FJ
    Toxicol Pathol; 2014; 42(2):414-21. PubMed ID: 23615430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DKK1 in relation to HCV induced liver cirrhosis and HCV induced HCC curative resection.
    Essa ES; Montaser BA; Badawy MT; Essa AS; Mokhtar MS
    Acta Gastroenterol Belg; 2016; 79(3):309-313. PubMed ID: 27821026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.